While ERK1/2s were highly phosphorylated in MS cells, the phosphorylation levels in BP cells is lower by 0.3 and 0.5-fold and the RNA expression levels for both ERK1 and ERK2 are not significantly different. The gene discussed is MAPK3; the disease is myeloid sarcoma.